Cooperation Seeking
Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced CSF1R antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.A recycling antibody combines two antibody engineering techniques: one is variable region engineering, which enables the antibody to bind to the antigen in the plasma and dissociate from the antigen in the endosome (after which the antigen undergoes lysosomal degradation), the other is constant region engineering to increase cellular uptake of antibody-antigen complexes into endosomes.
Related Products
All products and services are for Research Use Only. Do Not use in humans.
Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.